Yesterday, Senate Health, Education, Labor, and Pensions (HELP) held a hearing, Examining Our COVID-19 Response: Improving Health Equity and Outcomes by Addressing Health Disparities. Here’s what was said about equitable access to vaccines—and why clinical trial diversity matters.
Democrats and Republicans agreed: COVID-19 has had a disproportionate impact on low-income, minority, and rural communities. The pandemic exposed “cracks” in the U.S. health care system, as Ranking Member Richard Burr (R-NC) put it, which must be addressed.
This starts with equitable access to vaccines—but requires more than simply making doses available to these communities. Senators and witnesses discussed the need for access to things like broadband internet and transportation, removing financial barriers, and making vaccine information available in “plain and multiple languages,” said Taryn Williams of the Center for American Progress.
Visit www.COVIDVaccineFacts.org for vaccine information in English and Spanish.
“Actions must be at the local level,” said Dr. Consuelo Wilkins of the Vanderbilt Medical Center. (ICYMI: BIO’s Dr. Michelle McMurry-Heath recently went on a virtual “media tour” to discuss COVID-19 vaccines on local TV and radio stations in 15 markets across the country.)
And we must improve clinical trial diversity. Sen. Tim Scott (R-SC) asked how we can make trials more diverse. Gene Woods of Atrium Health stressed the importance of speaking to people “in their language” about trials and proposed an FDA mandate of minority representation in all trials.
A lack of education about what clinical trials are and how they work contributes to mistrust, Phyllis Arthur, BIO’s VP of Infectious Diseases and Diagnostics, recently told Endpoints News.
“I want a patient to know that…when a physician or clinician is suggesting they get this product, that the patient understands how that product might work in them,”she said. “It’s important to have that as our thought process when we’re doing clinical trials.”
P.S. In honor of Women’s History Month, BIO hosted a virtual event for the patient advocate community featuring three inspiring women who founded and developed patient advocacy organizations, including the Susan G. Komen Foundation’s Ambassador Nancy Brinker. Read our recap with four takeaways for the industry and patient advocates to know.
More Health Care News:
The New York Times: Pfizer begins testing its vaccine in young children
“Results from the trial are expected in the second half of the year, and the company hopes to vaccinate younger children early next year.”